Decision

CAP bridging mechanism products

A list of centrally authorised product (CAP) bridging mechanism products registered by the UK Licensing Authority.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 6 September 2023
• Last updated: 29 May 2024
  Show all updates

  1. 29 May 2024

     Moved 'Tecentriq 1,875 mg solution for injection' to expired CAP bridging list

  2. 17 April 2024

     Moved 'Casgevy 4-13 x 10^6 cells/mL dispersion for infusion' to Expired CAP Bridging list

  3. 16 November 2023

     Active CAP Bridging List updated with new entry: Casgevy

  4. 6 September 2023

     First published.

Documents

Active CAP bridging list

HTML

Expired CAP Bridging List

HTML

Details

The CAP bridging list comprises:

A GB licenced product (PLGB) to Northern Ireland for a period of 6 months or until the EC authorises a CAP in Northern Ireland or the EC refuses an application for the product, whichever is sooner.

For further information, read our CAP bridging mechanism guidance.